Tripos to Buy Optive, NIH to Award $4M for Cheminformatics, Dynameomics Project, Nonlinear Dynamics, Accelrys | GenomeWeb

Tripos to Buy Optive for $8M

Tripos last week said that it plans to acquire privately held discovery informatics firm Optive Research in a cash-and-stock transaction worth $8 million.

Tripos will issue 599,521 shares of its common stock and $4.75 million in cash to Optive’s shareholders. Tripos said that the cash portion will be funded through the issuance of $3.5 million of subordinated debt, 111,606 shares of common stock, and warrants to purchase 156,250 shares of common stock.

The acquisition is expected to close in January 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.